Eli Lilly (NYSE: LLY) reported new Phase 1 data for Sofe-M plus bevacizumab in platinum-sensitive ovarian cancer patients.

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported Q2 CY2026 results , with sales up 47.7% year on year to $22.97 billion. The company’s full-year revenue guidance of $86 billion at the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported Q1 CY2026 results , with sales up 55.5% year on year to $19.8 billion. The company’s full-year revenue guidance of $83.5 billion at the ...

Eli Lilly remains a buy after Q2, with robust revenue growth and strong performance from Mounjaro and Zepbound. LLY raised 2026 revenue guidance to $85–87 billion, driven by volume gains despite price ...

Although Eli Lilly’s (LLY) stock price has pulled back from its recent high, its core growth logic has not changed. Tirzepatide continues to gain volume, federal Medicare coverage opens up new ...

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Global pharmaceutical company Eli Lilly (NYSE: LLY) ...

The last time I spoke about Eli Lilly (LLY) it was with respect to a Seeking Alpha article entitled "Eli Lilly: Orforglipron Sets Path of Continued Revenue Growth In T2D And Obesity." With respect to ...

Eli Lilly's Q4 earnings beat, bullish Barclays coverage with 32% upside, and strong long-term Omvoh data highlight growth beyond GLP-1 drugs. Despite a slight dip in its share price on Friday, Eli ...

Feb 4 (Reuters) - Eli Lilly forecast strong growth for 2026 on Wednesday ‌on the back of surging obesity drug demand, shaking off pricing pressures ‌that helped sink rival Novo Nordisk's outlook. The ...

Explore the exciting world of Eli Lilly (NYSE: LLY) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends ...